- Home
- ยป
- Products & Services
- »
- Injectable Products
Injectable Products
Kenacort Hexa Injection Triamcinolone hexacetonide 20mg Tricort
Product Brochure
| Injection Site | IM |
| Treatment | Joint inflammation, arthritis, autoimmune conditions |
| Strength | 20 mg |
| Brand | Kenacort Hexa, Tricort, Hexacort |
| Pharmacopoeia Standard | USP |
| Composition | Triamcinolone Acetonide |
| Packaging | 1 ml |
| Manufacturer | Abbott |
Overview
Kenacort Hexa contains Triamcinolone Hexacetonide 20 mg, a long-acting corticosteroid for intra-articular, soft tissue, and joint injections. It provides potent anti-inflammatory effects to reduce pain, swelling, and stiffness in musculoskeletal and joint disorders, comparable to Tricort.
Uses
- Management of rheumatoid arthritis and osteoarthritis
- Treatment of synovitis and joint inflammation
- Relief from bursitis and tendinitis
- Intra-articular therapy for localized musculoskeletal inflammation
Benefits
- Provides powerful and long-lasting anti-inflammatory effect
- Reduces joint pain, swelling, and stiffness
- Improves mobility and functional activity
- Convenient injection for targeted therapy
- Well-tolerated when administered under medical supervision
BOTOX Botulinum Toxin Type A Ph. Eur
Product Brochure
| Strength | 50 Units |
| Brand | BOTOX |
| Form | Powder for Injection |
| Toxin Type | Type A |
| Packaging Type | Vial |
| Composition | Botulinum Toxin Type A |
| Route | Intramuscular / Intradermal injection |
BOTOX Botulinum Toxin Type A Ph. Eur contains botulinum toxin type A, a neurotoxin that works by temporarily blocking nerve signals to muscles, resulting in muscle relaxation. It is used in both therapeutic and aesthetic applications.
Uses:
- Management of muscle spasticity
- Treatment of cervical dystonia
- Management of chronic migraine
- Treatment of overactive bladder
- Reduction of facial wrinkles (cosmetic use)
Benefits:
- Relaxes targeted muscles effectively
- Helps reduce pain and muscle stiffness
- Improves functional movement in spastic conditions
- Provides cosmetic improvement by smoothing wrinkles
- Offers long-lasting effects with periodic administration
Omalizumab 150mg Omalirel Injection - Xolair
| Strength | 150mg |
| Pack Size | 1 Vial |
| Brand | Xolair |
| Patient Type | Adults & Children |
| Usage | Severe Asthma |
| Route | Subcutaneous |
| Therapeutic Class | Monoclonal Antibody / Anti-IgE |
| Manufactured by | Novartis |
| Composition | Omalizumab |
Brand Name: OMALIREL 150
Generic Name: Omalizumab
Reference Brand: Xolair
Composition: Omalizumab 150 mg
Dosage Form: Lyophilized Powder for Injection / Prefilled Syringe
Therapeutic Class: Monoclonal Antibody / Anti-IgE
Indication: Moderate to severe allergic asthma, chronic spontaneous (idiopathic) urticaria
Administration Route: Subcutaneous
Age Group: Adults & Children
OMALIREL 150 is a targeted biologic therapy developed to neutralize immunoglobulin E (IgE), a central mediator in allergic conditions. Designed as a comparable alternative to Xolair, it provides effective control over persistent allergic responses that are inadequately managed with standard treatments.
By intervening early in the allergic cascade, this formulation helps reduce symptom severity, frequency of exacerbations, and dependence on conventional therapies. It is particularly valuable in long-term disease modulation for patients with chronic allergic disorders.
โญ Key Benefits- Targeted IgE inhibition
- Reduces asthma exacerbations
- Effective in chronic urticaria
- Suitable for difficult-to-control allergic cases
- Improves overall disease management
Omalizumab binds selectively to free IgE antibodies, preventing their interaction with mast cells and basophils. This reduces the release of inflammatory mediators responsible for allergic reactions.
๐ Usage Guidelines- Administer subcutaneously under medical supervision
- Dose determined based on serum IgE levels and body weight
- Typically administered every 2–4 weeks
Cerevate 60mg Cerebroprotein Injection
| Strength | 60 mg/ml |
| Pack Size | 1 ml |
| Usage | Alzheimer's disease |
| Packaging Type | Vial |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Brand. | Cerevate |
Cerevate 60mg Injection is given under the supervision of a healthcare professional only. You may take it at the same time each day to maintain consistent level of medicine in the blood. If you miss any dose, take it as soon as you remember. Do not skip any doses and finish the full course of treatment even if you feel better. It is important that this medication is not stopped without talking to doctor. Do not take this medicine if you are suffering from epilepsy or severe kidney problem.
It is not known to cause serious side effects but injection site reaction (pain or redness), nausea, headache and vertigo may occur. It may also cause dizziness and sleepiness, so do not drive or do anything that requires mental focus until you know how this medicine affects you.
- Alzheimer's disease
- Stroke
- Head injury
Antithymocyte immunoglobulins (250mg) (Thymogam)
Product Brochure
| Strength | 250 mg |
| Packaging Size | 5 ml Vial |
| Brand | Thymogam |
| Usage | IV Use |
| Treatment | immune suppression therapy |
| Storage | Below 25 Deg C |
| Country Of Origin | India |
| Manufacturer. | Bharat Serums |
Brand Name: THYMOGAM 250
Composition: Anti-Thymocyte Immunoglobulin (Equine) 250 mg
Dosage Form: Lyophilized Powder for Injection
Therapeutic Class: Immunosuppressant
Indication: Aplastic anemia, prevention and treatment of organ transplant rejection
Administration Route: Intravenous Infusion
Age Group: Adults & Children
THYMOGAM 250 is a potent immunosuppressive biologic formulated to provide targeted suppression of immune activity in critical clinical conditions. Derived as anti-thymocyte immunoglobulins, it acts specifically on T-lymphocytes, which are central to immune-mediated tissue damage and graft rejection.
Its high-strength formulation is particularly suited for intensive immunosuppression protocols, enabling effective control in conditions such as aplastic anemia and organ transplantation. Designed for precision and reliability, it supports improved therapeutic outcomes by modulating immune responses in a controlled and predictable manner.
โญ Key Benefits- Targeted suppression of T-lymphocytes
- Reduces risk of transplant rejection
- Effective in severe aplastic anemia
- Suitable for intensive immunosuppressive therapy
- Supports improved clinical outcomes
Anti-thymocyte immunoglobulins bind to T-cells, leading to their depletion and suppression of immune-mediated responses.
๏ฟฝ๏ฟฝ UsageTHYMOGAM 250 is used in immune suppression therapy for serious hematological and transplant conditions.
It is typically used for:
- Aplastic anemia
- Prevention of organ transplant rejection
- Treatment of acute rejection episodes
Administered as:
- Slow intravenous infusion
- In hospital settings with monitoring
- Under specialist supervision
Telipsa Injection (Terlipressin 1Mg/10Ml)
Product Brochure
| Strength | 1mg |
| Packaging Size | 1 Vial |
| Brand Name | Telipsa |
| Volume per Vial | 10 ml |
| Form | Injection |
| Manufacturer | INTAS |
Doricrit Doripenem 500mg Injection
Product Brochure
| Strength | 500 mg |
| Brand | Doricrit |
| Pack Type | Vial |
| Route | IV |
| Composition | Doripenem |
| Manufactured By | Cipla |
| Pack Size | 1 Vial |
Brand Name: Doricrit
Generic Name: Doripenem
Strength: 500 mg
Dosage Form: Powder for Injection (IV)
Therapeutic Category: Carbapenem Antibiotic
Manufacturer/Marketer: Cipla Ltd.
Doricrit 500mg Injection contains doripenem, a broad-spectrum carbapenem antibiotic used for the treatment of severe bacterial infections. It is highly effective against a wide range of Gram-positive and Gram-negative bacteria, including multidrug-resistant strains.
Doripenem works by inhibiting bacterial cell wall synthesis, leading to the destruction of bacteria. It is commonly used in hospital settings for serious infections where other antibiotics may not be effective.
Indications / Uses- Complicated intra-abdominal infections
- Complicated urinary tract infections (including pyelonephritis)
- Hospital-acquired pneumonia (including ventilator-associated pneumonia)
- Severe bacterial infections caused by susceptible organisms
Doripenem binds to penicillin-binding proteins (PBPs), disrupting bacterial cell wall synthesis. This results in bacterial cell lysis and death.
Dosage & Administration- Administered via intravenous (IV) infusion
- Dosage depends on infection type, severity, and renal function
- Typically given every 8 hours
- Should be administered under medical supervision
Pause Tranexamic 500mg Injection
Product Brochure
| Strength | 500 mg/5 ml |
| Packaging Size | 5 x 5ml Ampoules |
| Brand | Pause, Tranexa, Kapron |
| Route of Administration | IV |
| Manufactured By | Emcure Pharmaceuticals Ltd |
| Composition | Tranexamic Acid (500mg) |
| Treatment | Bleeding Disorders, Heavy Menstrual Bleeding |
Brand Name: Pause
Generic Name: Tranexamic Acid
Strength: 500 mg
Dosage Form: Injection (IV/IM)
Therapeutic Category: Antifibrinolytic / Hemostatic Agent
Manufacturer/Marketer: Mankind Pharma Ltd.
Pause Tranexamic Acid 500mg Injection contains tranexamic acid, an antifibrinolytic agent used to control and prevent excessive bleeding. It works by inhibiting the breakdown of fibrin clots, thereby stabilizing blood clots and reducing blood loss.
This injection is widely used in surgical procedures, trauma care, and conditions associated with abnormal bleeding. It is also effective in managing heavy menstrual bleeding and preventing hemorrhage in various clinical settings.
Indications / Uses- Control of surgical bleeding
- Trauma-related hemorrhage
- Heavy menstrual bleeding (menorrhagia)
- Postpartum hemorrhage
- Dental procedures in bleeding disorders
- Epistaxis (nosebleeds)
Tranexamic acid competitively inhibits the activation of plasminogen to plasmin, preventing fibrin degradation. This stabilizes blood clots and helps reduce excessive bleeding.
Dosage & Administration- Administered via intravenous (IV) or intramuscular (IM) route
- Dosage depends on indication and severity
- Should be administered under medical supervision
Perzea 420 Mg Pertuzumab Injection
Product Brochure
| Strength | 420 mg |
| Pack Size | 14 ml |
| Brand | Perzea |
| Manufacturer | Roche |
| Route of Administration | IV Infusion |
| Dosage Form | IV Solution |
| Concentration | 30 mg/ml |
| Formulation Type | Solution Concentrate |
| Composition | Pertuzumab |
Perzea 420 mg Pertuzumab Injection contains pertuzumab, a monoclonal antibody that targets the HER2 receptor, helping to inhibit the growth and survival of cancer cells. It is used in the treatment of HER2-positive cancers.
Uses:
- Treatment of HER2-positive breast cancer
- Management of metastatic or early-stage HER2-positive breast cancer
Benefits:
- Specifically targets HER2 receptors on cancer cells
- Helps inhibit tumor growth and spread
- Enhances effectiveness when used in combination with other therapies
- Supports improved treatment outcomes in HER2-positive cancers
Borenat 2 Mg Bortezomib Injection
Product Brochure
| Strength | 2 mg |
| Brand | Bortenat |
| Pack Size | Vial |
| Form | Lyophilized |
| Route | SC, IV |
| Usage | Lymphoma, Multiple Myeloma |
| Manufacturer | Natco Pharma |
Borenat 2 mg Bortezomib Injection contains bortezomib, a proteasome inhibitor that works by disrupting protein degradation in cancer cells, leading to cell death. It is used in the treatment of certain hematological malignancies.
Uses:
- Treatment of multiple myeloma
- Management of mantle cell lymphoma
Benefits:
- Induces cancer cell death by inhibiting proteasome activity
- Helps control disease progression
- Supports improved treatment outcomes in blood cancers
- Effective component of combination therapy regimens
Snake Venom Antiserum I.P.
| Type | Polyvalent |
| Form | Lyophilized |
| Brand | Bharat Serums |
| Volume per Vial | 10 ml |
| Usage | Human Use |
| Packaging Type | Vial |
Adenoz 6mg Injection
| Route Of Administration | Intravenous |
| Brand | Adenoz |
| Container Type | Ampule |
| Strength | 6 mg / 2 ml |
| Pharmacopoeia Standard | IP |
| Composition | Adenosine Monophosphate |
| Manufacturer | Celon Laboratories Pvt Ltd |
| Composition. | Adenosine |
| Dosage Form. | Injeaction |
Brand Name: ADENOZ
Composition: Adenosine 6 mg
Dosage Form: Injection
Therapeutic Class: Antiarrhythmic Agent
Indication: Paroxysmal supraventricular tachycardia (PSVT), diagnostic aid in cardiac arrhythmias
Administration Route: Intravenous (rapid bolus)
Age Group: Adults & Children
ADENOZ is a rapid-acting antiarrhythmic injection designed for immediate correction of certain types of abnormal heart rhythms. Known for its ultra-short duration of action, it provides quick and controlled interruption of re-entrant electrical pathways in the heart, allowing restoration of normal sinus rhythm within seconds.
Its precise pharmacological profile makes it an essential tool in emergency and critical care settings, where rapid diagnosis and treatment of supraventricular tachycardia are required. The formulation allows clinicians to achieve both therapeutic and diagnostic outcomes with high reliability.
โญ Key Benefits- Rapid conversion of abnormal heart rhythm to normal
- Ultra-short acting for controlled intervention
- Useful for both treatment and diagnosis
- Immediate onset of action
- Essential in emergency cardiac care
Adenosine slows conduction through the atrioventricular (AV) node, temporarily blocking abnormal electrical circuits and restoring normal heart rhythm.
๐ UsageADENOZ is used in management of rapid heart rhythm disorders.
It is typically used for:
- Paroxysmal supraventricular tachycardia (PSVT)
- Diagnosis of complex arrhythmias
- Rapid heart rate control in emergency settings
Administered as:
- Rapid intravenous bolus injection
- Followed by saline flush
- Under continuous cardiac monitoring
Supraplase Tenecteplase 40mg Injection (Metalyse TNKase)
| Strength | 40 mg |
| Packaging Type | Kit |
| Physical Form | Lyophilized Powder for Injection with Diluent |
| Brand | Supraplase |
| Usage/Application | acute heart attack |
| Composition | Tenecteplase |
| Packaging Size | 1 |
| Manufacturer. | Cadila |
| Therapeutic Class | Thrombolytic Agent |
Generic Name: Tenecteplase
Reference Brands: Metalyse, TNKase
Composition: Tenecteplase 40 mg
Dosage Form: Lyophilized Powder for Injection with Diluent
Therapeutic Class: Thrombolytic Agent (Fibrinolytic)
Indication: Acute ST-Elevation Myocardial Infarction (STEMI)
Administration Route: Intravenous (Single Bolus)
Age Group: Adults
๐งพ Product Description
SUPRAPLASE 40 is a genetically engineered fibrinolytic agent designed for rapid clot dissolution in acute myocardial infarction. Developed as a comparable alternative to Metalyse and TNKase, it offers high fibrin specificity and resistance to plasminogen activator inhibitor-1 (PAI-1), enabling effective thrombolysis.
Its single-bolus administration provides a significant advantage in emergency settings, allowing quick intervention and improved patient outcomes when time is critical.
โญ Key Benefits- Rapid clot dissolution in acute MI
- Single IV bolus for ease of administration
- High fibrin specificity
- Improved coronary blood flow
- Critical in emergency cardiac care
Tenecteplase binds to fibrin in thrombi and converts plasminogen to plasmin, leading to breakdown of fibrin clots and restoration of blood flow in occluded coronary arteries.
๐ UsageSUPRAPLASE 40 is used in emergency management of acute ST-elevation myocardial infarction (STEMI) to dissolve blood clots in coronary arteries and restore myocardial perfusion.
It is typically administered:
- As a single intravenous bolus
- As early as possible after onset of symptoms
- In hospital or emergency care settings under specialist supervision
Fluorescein Fluresin 20% Injection - Fluorescite
| Brand | Fluresin |
| Strength | 20% |
| Pack Size | 5 vials |
| Packaging Type | Vial |
| Usage | Diagnostics |
| Manufactured by | SL Samarth |
| Composition | Fluorescein Sodium |
Generic Name: Fluorescein Sodium
Reference Brand: Fluorescite
Composition: Fluorescein Sodium 20% w/v
Dosage Form: Injection
Therapeutic Class: Diagnostic Agent (Ophthalmic)
Indication: Fundus fluorescein angiography (FFA), retinal vascular disorders, ophthalmic diagnostics
Administration Route: Intravenous
Age Group: Adults
๐งพ Product Description
FLURESIN 20% is a high-precision diagnostic formulation used in ophthalmology for detailed visualization of retinal and choroidal circulation. Designed as a comparable alternative to Fluorescite, it enables clear imaging during fluorescein angiography, aiding in the detection and evaluation of vascular abnormalities.
Its rapid distribution and strong fluorescence properties allow clinicians to obtain high-contrast images, facilitating accurate diagnosis of conditions such as diabetic retinopathy, macular degeneration, and retinal vessel occlusions.
โญ Key Benefits- High-contrast retinal imaging
- Rapid circulation and visualization
- Essential for diagnostic precision
- Reliable performance in angiography procedures
- Supports early detection of retinal disorders
Fluorescein sodium emits fluorescence when exposed to specific wavelengths of light. After intravenous administration, it circulates through retinal vessels, allowing visualization of blood flow and vascular integrity during imaging.
๐ Usage Guidelines- Administer intravenously under medical supervision
- Used in controlled clinical settings
- Imaging performed immediately after injection
Kenadion Phytomenadione 10mg Injection - Konakion
| Strength | 1 mg / 0.5 ml |
| Pack Size | 5 x 5 x 0.5 ml |
| Pack Type | Ampoule |
| Route | Intramuscular / Intravenous / Subcutaneous |
| Brand | Kenadion |
| Form | Injection |
| Manufacturer | SL Samarth |
Brand Name: KENADION
Composition: Phytomenadione (Vitamin K1) 10 mg
Dosage Form: Injection
Therapeutic Class: Vitamin / Antihemorrhagic Agent
Indication: Vitamin K deficiency, bleeding disorders, anticoagulant reversal, neonatal prophylaxis
Administration Route: Intramuscular / Intravenous / Subcutaneous (as directed)
Age Group: Adults & Neonates
KENADION is a vital antihemorrhagic formulation designed to restore normal blood coagulation in conditions associated with vitamin K deficiency or impaired clotting mechanisms. As a bioactive form of Vitamin K1, it plays a crucial role in the synthesis of clotting factors, enabling effective control of bleeding.
This formulation is widely used in both emergency and preventive care, including reversal of anticoagulant effects and prevention of hemorrhagic disease in newborns. Its reliable and rapid action makes it an essential component in clinical settings where correction of coagulation status is required.
โญ Key Benefits- Restores normal blood clotting function
- Effective in managing vitamin K deficiency
- Reverses effects of anticoagulants
- Prevents bleeding complications in newborns
- Suitable for emergency and preventive use
Phytomenadione acts as a cofactor in the hepatic synthesis of clotting factors II, VII, IX, and X, thereby restoring normal coagulation processes.
๐ UsageKENADION is used in management and prevention of bleeding disorders related to vitamin K deficiency.
It is typically used for:
- Vitamin K deficiency bleeding
- Reversal of anticoagulant effects (e.g., warfarin)
- Prevention of hemorrhagic disease in newborns
- Bleeding due to impaired clotting factor synthesis
Administered as:
- Intramuscular or intravenous injection
- Under medical supervision
- Dosage based on clinical condition
RENOCEL 4000 ERYTHOPOIETIN INJECTION RECOMBINANT HUMAN ERYTHOPOIETIN INJECTION
| Strength | 4000 IU |
| Dose Form | PFS |
| Brand | Renocel |
| Molecule | Epoetin Alfa |
| Pack Size | Single PFS |
| Manufacturer | INTAS |
| Route. | Subcutaneous / Intravenous |
Brand Name: RENOCEL 4000
Composition: Recombinant Human Erythropoietin 4000 IU
Dosage Form: Injection
Therapeutic Class: Hematopoietic Agent
Indication: Anemia associated with chronic kidney disease, chemotherapy-induced anemia, anemia in surgical patients
Administration Route: Subcutaneous / Intravenous
Age Group: Adults & Children
RENOCEL 4000 is a biologically engineered erythropoietin formulation designed to stimulate red blood cell production in patients with anemia. It closely mimics the natural hormone responsible for erythropoiesis, helping restore hemoglobin levels and improve oxygen-carrying capacity of the blood.
This formulation is particularly valuable in chronic conditions such as kidney disease and chemotherapy-related anemia, where endogenous erythropoietin levels are insufficient. Its precise and controlled action supports gradual correction of anemia, enhancing patient energy levels and overall functional capacity.
โญ Key Benefits- Stimulates red blood cell production
- Improves hemoglobin levels
- Reduces need for blood transfusions
- Enhances oxygen delivery in the body
- Suitable for long-term anemia management
Recombinant erythropoietin stimulates bone marrow to produce red blood cells by acting on erythroid progenitor cells.
๐ UsageRENOCEL 4000 is used in management of anemia due to reduced erythropoietin levels.
It is typically used for:
- Chronic kidney disease-related anemia
- Chemotherapy-induced anemia
- Anemia in patients undergoing major surgery
Administered as:
- Subcutaneous or intravenous injection
- At intervals prescribed by physician
- With regular hemoglobin monitoring
450Mg Kemocarb Carboplatin Injection
| Strength | 450 mg |
| Vial Volume | 45 ml |
| Brand | Kemocarb |
| Concentration | 10 mg/ml |
| Form | Injection |
| Route | IV |
| Manufacturer | Fresenius Kabi |
| Usage | Ovarian Cancer, Lung Cancer |
| Packaging Size | 1 Vial |
Kemocarb 450mg Injection contains Carboplatin, an anti-cancer medicine used in the treatment of various types of cancers.
It is commonly prescribed for cancers such as ovarian cancer, lung cancer (especially non-small cell lung cancer), and other solid tumors. It may be used alone or in combination with other chemotherapy medicines to improve treatment outcomes.
Kemocarb 450mg Injection is administered intravenously by a qualified healthcare professional in a hospital or oncology setting. The dosage is carefully calculated based on body surface area, kidney function, and the patient’s overall condition. It is important to follow the prescribed treatment schedule strictly.
Before starting treatment, inform your doctor about any existing medical conditions, especially kidney problems, blood disorders, or previous chemotherapy. If you are pregnant or breastfeeding, consult your doctor before using this medicine.
Uses of Kemocarb 450mg Injection- Treatment of ovarian cancer
- Treatment of lung cancer
- Management of other solid tumors
Kemocarb 450mg Injection works by slowing or stopping the growth of cancer cells. It helps shrink tumors, control disease progression, and improve overall treatment effectiveness when used as part of combination chemotherapy.
How to Use Kemocarb 450mg Injection- Administered intravenously by a healthcare professional
- Not for self-administration
- Dosage is individualized based on patient-specific factors
- Regular monitoring is required during treatment
Carboplatin is a platinum-based compound that interferes with the DNA of cancer cells. It forms cross-links in DNA strands, preventing cell division and leading to the death of rapidly dividing cancer cells.
Pamorelin La Injection
| Physical Form | Powder |
| Manufacturer | Dr Reddys Laboratories |
| Packaging Size | 1 Vial |
| Dosage Form | Lypholized Powder |
| Salt Composition | Triptorelin |
| Strength | 22.5 mg |
| Treatment | Prostate Cancer |
Pamorelin LA Injection contains Triptorelin, a hormone therapy medicine used in the treatment of hormone-dependent conditions.
It is commonly prescribed for Prostate Cancer, Endometriosis, and Precocious Puberty. It works by reducing the production of certain hormones (like testosterone and estrogen), which helps slow disease progression and relieve symptoms.
Pamorelin LA Injection is a long-acting formulation administered by a healthcare professional, usually as an intramuscular or subcutaneous injection at specific intervals (monthly, quarterly, or as prescribed).
Before starting treatment, inform your doctor about any medical conditions or medications you are taking. If you are pregnant or breastfeeding, consult your doctor before using this medicine.
Uses of Pamorelin LA Injection- Treatment of prostate cancer
- Management of endometriosis
- Treatment of central precocious puberty
Pamorelin LA Injection helps control the production of sex hormones, which are responsible for the progression of certain diseases. This leads to reduced tumor growth in prostate cancer, relief from endometriosis symptoms, and normalization of early puberty in children.
How to Use Pamorelin LA Injection- Administered by a healthcare professional (IM or subcutaneous)
- Not for self-administration
- Given at regular intervals as prescribed
Triptorelin is a gonadotropin-releasing hormone (GnRH) agonist. It initially stimulates and then suppresses the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to a decrease in testosterone or estrogen levels, depending on the patient.
Artesunate Injection 30mg / 60mg / 120mg (Johnlee)
| Dosage Form | Injection |
| Brand | Artesunate |
| Route of Administration | IV or IM |
| Usage | Emergency |
| Manufacturer | Johnlee |
| Strength | 120 mg |
Johnlee Artesunate Injection contains Artesunate, a fast-acting antimalarial medicine used in the treatment of severe Malaria, especially cases caused by Plasmodium falciparum.
It is commonly used in emergency and hospital settings for severe or complicated malaria, where rapid action is required. Artesunate helps quickly reduce the number of parasites in the blood, improving patient outcomes and reducing the risk of complications.
Johnlee Artesunate Injection is available in strengths of 30 mg, 60 mg, and 120 mg and is administered intravenously or intramuscularly by a healthcare professional. The dosage depends on body weight and severity of infection, followed by oral antimalarial therapy as per treatment guidelines.
Before starting treatment, inform your doctor about any existing medical conditions or medications. Prompt treatment is essential in severe malaria to prevent life-threatening complications.
Uses of Artesunate Injection- Treatment of severe malaria
- Management of complicated Plasmodium falciparum malaria
Artesunate Injection acts rapidly to kill malaria parasites in the bloodstream. It reduces parasite load quickly, helping stabilize the patient and prevent serious complications such as organ failure or death.
How to Use Artesunate Injection- Administered intravenously or intramuscularly by a healthcare professional
- Not for self-administration
- Dose is based on body weight and clinical condition
- Usually followed by oral antimalarial medication
Artesunate works by generating reactive oxygen species inside malaria parasites, damaging their proteins and cell membranes. This leads to rapid destruction of the parasites and helps clear the infection from the bloodstream.
Magneon Magnesium Sulphate 50% Injection
| Concentration | 50 % |
| Pharmacopoeia Standard | IP |
| Brand | Magneon |
| Packaging Size | 10 x 5 x 2 ml |
| Packaging Type | Ampoule |
| Active Ingredient | Magnesium Sulphate |
| Dosage Form | Injection |
| Manufacturer | Neon Laboratories Ltd |
Magneon 50% Injection contains Magnesium Sulphate, a medication used in the management of magnesium deficiency and certain critical conditions.
It is commonly used in obstetric care for the prevention and treatment of seizures in eclampsia and pre-eclampsia, as well as in other medical emergencies.
Key Product Details- Brand Name: Magneon
- Generic Name: Magnesium Sulphate
- Strength: 50% w/v
- Dosage Form: Injection
- Pack Size: Typically 2 ml / 5 ml / 10 ml ampoule (may vary)
- Pack Type: Ampoule
- Manufacturer / Marketer: Neon Laboratories Ltd
- Route of Administration: Intravenous / Intramuscular
- Storage: Store below 25°C
- Treatment and prevention of eclampsia and pre-eclampsia
- Management of magnesium deficiency
- Control of seizures
- Certain cardiac arrhythmias
Magneon helps prevent and control seizures in pregnant women with eclampsia, improving maternal safety and outcomes. It also stabilizes nerve and muscle function.
How to Use- Administered by a healthcare professional
- Given via intravenous or intramuscular route
- Dosage depends on clinical condition
Magnesium sulphate acts on the central nervous system to reduce neuromuscular excitability. It also stabilizes cell membranes and helps prevent seizures.
Neostigmine Myostigmin 0.5mg Injection 1ml
| Strength | 0.5 mg |
| Composition | Neostigmine Methylsulphate Injection |
| Packaging Type | Ampoule |
| Brand | Myostigmin |
| Dosage Form | Injection |
| Manufacturer | Neon Laboratories |
| Pack Size. | 10 x 5 x 2 ml |
Myostigmin 0.5mg Injection contains Neostigmine, a medicine used to improve muscle strength and reverse the effects of certain muscle relaxants.
It is commonly used in the management of myasthenia gravis and for reversal of neuromuscular blockade after surgical procedures.
Key Product Details- Brand Name: Myostigmin
- Generic Name: Neostigmine
- Strength: 0.5 mg/ml
- Dosage Form: Injection
- Pack Size: 1 ml ampoule
- Pack Type: Ampoule
- Manufacturer / Marketer: Samarth Life Sciences Pvt Ltd
- Route of Administration: Intravenous / Intramuscular / Subcutaneous
- Storage: Store below 25°C
- Treatment of myasthenia gravis
- Reversal of neuromuscular blockade
- Management of postoperative urinary retention
Myostigmin improves muscle strength by enhancing nerve signal transmission to muscles. It is especially useful in reversing the effects of muscle relaxants after surgery.
How to Use- Administered by a healthcare professional
- Given via IV, IM, or subcutaneous route
- Dosage depends on indication and patient condition
Neostigmine inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine. This increases acetylcholine levels at neuromuscular junctions, improving muscle contraction and strength.
Vorier Voriconazole 200mg Injection
| Strength | 200 mg |
| Pack Size | Single vial |
| Brand | Vorier |
| Injection Type | Lyophilized powder |
| Packaging Type | Glass vial |
| Shelf Life | 24 months |
| Composition | Voriconazole 200mg |
Brand Name: Vorier
Generic Name: Voriconazole
Strength: 200 mg
Dosage Form: Powder for Injection (IV Infusion)
Therapeutic Category: Antifungal (Triazole)
Manufacturer/Marketer: Zydus Lifesciences Ltd.
Vorier Voriconazole 200mg Injection contains voriconazole, a broad-spectrum triazole antifungal agent used in the treatment of serious and life-threatening fungal infections. It is particularly effective against invasive Aspergillus and Candida species, including infections resistant to other antifungal therapies.
Voriconazole works by inhibiting fungal cytochrome P450-dependent enzymes, thereby disrupting ergosterol synthesis—an essential component of fungal cell membranes. This leads to cell membrane damage and fungal cell death.
Indications / Uses- Invasive aspergillosis
- Candidemia and invasive candidiasis
- Serious fungal infections resistant to other antifungals
- Esophageal candidiasis
- Prophylaxis in high-risk immunocompromised patients
Voriconazole inhibits 14-alpha-demethylase, a fungal enzyme required for ergosterol synthesis. This disrupts fungal cell membrane integrity and inhibits fungal growth.
Dosage & Administration- Administered via intravenous (IV) infusion
- Loading dose followed by maintenance dosing
- Dosage depends on body weight and clinical condition
- Should be administered under medical supervision
Dalcinex Clindamycin 300mg Injection Cleocin
| Strength | 300 mg/2 ml |
| Packaging Size | 2 ml |
| Brand | Dalcinex |
| Composition | Clindamycin 300 mg |
| Route of Administration | IV/IM |
| Packaging Type | Ampoule |
| Manufacturer | Cipla Ltd |
Brand Names: Dalcinex, Cleocin
Generic Name: Clindamycin Phosphate
Strength: 300 mg
Dosage Form: Injection (IV/IM)
Therapeutic Category: Lincosamide Antibiotic
Manufacturer/Marketer: Pfizer Inc. (Cleocin reference)
Product DescriptionDalcinex Clindamycin 300mg Injection contains clindamycin, a lincosamide antibiotic used for the treatment of serious bacterial infections caused by susceptible anaerobic and Gram-positive organisms. It is particularly effective in infections where penicillin cannot be used or is ineffective.
Clindamycin works by inhibiting bacterial protein synthesis, thereby stopping the growth and spread of bacteria. It is commonly used in hospital settings for severe infections involving the skin, soft tissues, bones, joints, and internal organs.
Indications / Uses- Skin and soft tissue infections
- Bone and joint infections (osteomyelitis)
- Intra-abdominal infections
- Respiratory tract infections
- Pelvic and gynecological infections
- Dental infections
Clindamycin binds to the 50S ribosomal subunit of bacteria, inhibiting protein synthesis and preventing bacterial growth.
Dosage & Administration- Administered via intravenous (IV) or intramuscular (IM) route
- Dosage depends on infection severity and patient condition
- Should be administered under medical supervision
Arixtra 75 Mg Injection
| Strength | 2.5 mg |
| Packaging Size | 10 / 7 Injections |
| Brand Name | Arixtra |
| Manufacturer | Aspen |
| Form | Injection |
| Packaging Type | Pre-filled Syringe |
| Route of Administration | Subcutaneous, Intravenous |
Brand Name: Arixtra
Generic Name: Fondaparinux Sodium
Strength: 7.5 mg
Dosage Form: Injection (Subcutaneous)
Therapeutic Category: Anticoagulant / Factor Xa Inhibitor
Manufacturer/Marketer: GlaxoSmithKline
Arixtra 7.5 mg Injection contains fondaparinux sodium, a selective anticoagulant that inhibits Factor Xa, an essential component in the blood clotting cascade. It is used to prevent and treat thromboembolic disorders by reducing the formation of harmful blood clots.
Fondaparinux works by binding to antithrombin III, enhancing its ability to inhibit Factor Xa. This prevents thrombin formation and clot development without directly affecting platelet function.
Indications / Uses- Deep vein thrombosis (DVT) treatment and prevention
- Pulmonary embolism (PE)
- Prevention of venous thromboembolism after surgery
- Acute coronary syndromes (in specific cases)
Fondaparinux selectively inhibits Factor Xa via antithrombin III activation, preventing the conversion of prothrombin to thrombin and thereby reducing clot formation.
Dosage & Administration- Administered via subcutaneous injection
- Dosage based on patient body weight and indication
- Typically given once daily
- Should be administered under medical supervision
Sompraz Esomeprazole 40mg Injection
| Strength | 40 mg |
| Packaging size | 1 vial |
| Brand | Nexium IV, Esoz |
| Composition | Esomeprazole 40 mg |
| Injection type | Lyophilized |
| Pack type | Vial with box |
| Treatment | Acid reflux, GERD, ulcers |
Brand Name: Sompraz
Generic Name: Esomeprazole Sodium
Strength: 40 mg
Dosage Form: Injection (IV)
Therapeutic Category: Proton Pump Inhibitor (PPI)
Manufacturer/Marketer: Sun Pharmaceutical Industries Ltd.
Sompraz Esomeprazole 40mg Injection contains esomeprazole, a proton pump inhibitor (PPI) that effectively reduces gastric acid secretion. It is commonly used for the treatment of acid-related disorders, especially when oral administration is not feasible.
Esomeprazole works by selectively inhibiting the Hโบ/Kโบ-ATPase enzyme system (proton pump) in gastric parietal cells, thereby suppressing the final step in acid production. This leads to reduced gastric acidity, allowing healing of ulcers and relief from symptoms such as heartburn and acid reflux.
Indications / Uses- Gastroesophageal reflux disease (GERD)
- Peptic ulcer disease
- Zollinger–Ellison syndrome
- Prevention of stress ulcers in critically ill patients
- Management of upper gastrointestinal bleeding
Esomeprazole irreversibly blocks the gastric proton pump (Hโบ/Kโบ-ATPase), resulting in long-lasting suppression of gastric acid secretion and improved healing of acid-related damage.
Dosage & Administration- Administered via intravenous (IV) injection or infusion
- Dosage depends on clinical condition and severity
- Typically used when oral therapy is not possible
- Should be administered by a healthcare professional
Denoci-OP Injection (Denosumab 60mg)
| Strength | 60 mg |
| Packaging Type | Pre-filled Syringe |
| Brand | Denoci-OP |
| Manufacturer | Cipla |
| Packaging Size | 1 ml |
| Shelf Life | 36 month |
| Composition | Denosumab |
| Form | Solution for Injection |
Denoci-OP Injection (Denosumab 60mg) is a professionally formulated Pharmaceutical Product medication designed for the effective management of various medical conditions. At its core, this product contains Denoci-OP IP 60MG, an active pharmaceutical ingredient with a well-characterized safety and efficacy profile. The manufacturing processes employed by Cadila Healthcare Ltd. adhere to current Good Manufacturing Practice regulations, incorporating validated procedures and calibrated equipment to produce a medication of consistent quality.
The product is configured as a injection for intravenous / intramuscular use, reflecting established clinical preferences for this delivery route in the treatment of the indicated conditions. Formulation scientists have carefully selected excipients that complement the active ingredient, providing necessary functions such as binding, disintegration assistance, lubrication, and protection against environmental factors. These excipients are pharmaceutical grade and appear on regulatory-approved lists for the intended route of administration.
Denoci-OP has earned a substantial place in the pharmaceutical armamentarium through consistent demonstration of clinical benefit. When administered as directed, Denoci-OP Injection (Denosumab 60mg) delivers the active compound in quantities sufficient to produce the desired pharmacological response. The product comes with complete documentation including Certificate of Analysis, providing transparency regarding the quality parameters of each batch.
UsesDenoci-OP is prescribed by healthcare providers for a range of clinical indications. The primary therapeutic applications of this medication encompass the following conditions and clinical scenarios:
- Various Medical Conditions: Denoci-OP is widely used in the treatment of various medical conditions, where it has demonstrated consistent efficacy in clinical trials and routine clinical practice. Patients presenting with symptoms associated with various medical conditions may benefit significantly from a properly managed course of Denoci-OP therapy.
- Combination Therapy: Denoci-OP may be used as part of a multi-drug treatment regimen where combining therapeutic agents offers synergistic benefits. The attending physician determines the most appropriate combination based on individual patient characteristics and clinical response.
- Prophylactic Use: In certain clinical contexts, Denoci-OP may be employed as a preventive measure in patients identified as being at elevated risk for developing conditions associated with various medical conditions. Prophylactic protocols are established based on clinical guidelines and risk assessment.
- Maintenance Therapy: Following initial treatment response, Denoci-OP may continue to be administered at adjusted dosages to maintain the achieved therapeutic benefit and prevent disease relapse or progression.
- Supportive Care: As an adjunct to primary treatment measures, Denoci-OP contributes to comprehensive patient care by addressing specific aspects of the disease process that fall within its pharmacological scope of activity.
The prescribing healthcare professional evaluates the patient's complete medical history, current symptoms, and overall health status before determining whether Denoci-OP is the appropriate therapeutic choice. Individual patient responses may vary, and ongoing medical supervision is recommended throughout the treatment course to optimize outcomes and manage any emerging concerns.